Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP184773.RAQxV0sU_8q8Kt-4Juslwjb0w3K6Vq0fSwrL7dlrC9qmA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP184773.RAQxV0sU_8q8Kt-4Juslwjb0w3K6Vq0fSwrL7dlrC9qmA130_assertion type Assertion NP184773.RAQxV0sU_8q8Kt-4Juslwjb0w3K6Vq0fSwrL7dlrC9qmA130_head.
- NP184773.RAQxV0sU_8q8Kt-4Juslwjb0w3K6Vq0fSwrL7dlrC9qmA130_assertion description "[The aim was to explore the utility for staging and prognostic impact of carcinoembryonic antigen (CEA), cytokeratin 20 (CK20), guanylyl cyclase C (GCC), CUB (complement protein subcomponents C1r/C1s, urchin embryonic growth factor, and bone morphogenic protein 1) containing domain protein 1 (CDCP1) and mucin 2 (MUC2) mRNA levels in mesenteric lymph nodes of colorectal cancer (CRC) patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP184773.RAQxV0sU_8q8Kt-4Juslwjb0w3K6Vq0fSwrL7dlrC9qmA130_provenance.
- NP184773.RAQxV0sU_8q8Kt-4Juslwjb0w3K6Vq0fSwrL7dlrC9qmA130_assertion evidence source_evidence_literature NP184773.RAQxV0sU_8q8Kt-4Juslwjb0w3K6Vq0fSwrL7dlrC9qmA130_provenance.
- NP184773.RAQxV0sU_8q8Kt-4Juslwjb0w3K6Vq0fSwrL7dlrC9qmA130_assertion SIO_000772 21618511 NP184773.RAQxV0sU_8q8Kt-4Juslwjb0w3K6Vq0fSwrL7dlrC9qmA130_provenance.
- NP184773.RAQxV0sU_8q8Kt-4Juslwjb0w3K6Vq0fSwrL7dlrC9qmA130_assertion wasDerivedFrom befree-20140225 NP184773.RAQxV0sU_8q8Kt-4Juslwjb0w3K6Vq0fSwrL7dlrC9qmA130_provenance.
- NP184773.RAQxV0sU_8q8Kt-4Juslwjb0w3K6Vq0fSwrL7dlrC9qmA130_assertion wasGeneratedBy ECO_0000203 NP184773.RAQxV0sU_8q8Kt-4Juslwjb0w3K6Vq0fSwrL7dlrC9qmA130_provenance.